1. |
黄佳, 黄浩贤, 陆立基, 等. 阻塞性睡眠呼吸暂停综合征患者困难气道评估的研究. 实用医学杂志, 2024, 40(10): 1460-1466.
|
2. |
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med, 2019, 7(8): 687-698.
|
3. |
Kapur VK, Baldwin CM, Resnick HE, et al. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep, 2005, 28(4): 472-477.
|
4. |
Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med, 2011, 183(10): 1419-1426.
|
5. |
Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J, 2009, 34(1): 243-260.
|
6. |
McNicholas WT, Bonsigore MR, Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J, 2007, 29(1): 156-178.
|
7. |
McColl MD, Ellison J, Greer IA, et al. Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol, 2000, 108(2): 272-274.
|
8. |
Hawkins D. The role of oral direct thrombin inhibitors in the prophylaxis of venous thromboembolism. Pharmacotherapy, 2004, 24(10): 179S-183S.
|
9. |
Arzt M, Luigart R, Schum C, et al. Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism. Eur Respir J, 2012, 40(4): 919-924.
|
10. |
D’Apuzzo MR, Browne JA. Obstructive sleep apnea as a risk factor for postoperative complications after revision joint arthroplasty. J Arthroplasty, 2012, 27(Suppl 8): 95-98.
|
11. |
Mraovic B, Hipszer BR, Epstein RH, et al. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty, 2010, 25(1): 64-70.
|
12. |
Memtsoudis S, Liu SS, Ma Y, et al. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg, 2011, 112(1): 113-121.
|
13. |
Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520, 000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet, 2018, 50(4): 524-537.
|
14. |
Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ, 2018, 362: k601.
|
15. |
Hemani G, Zheng J, Elsworth B, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife, 2018, 7: e34408.
|
16. |
Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol, 2017, 46(6): 1734-1739.
|
17. |
Osman AM, Carter SG, Carberry JC, et al. Obstructive sleep apnea: current perspectives. Nat Sci Sleep, 2018, 10: 21-34.
|
18. |
Lippi G, Mattiuzzi C, Franchini M. Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost, 2015, 114(5): 958-963.
|
19. |
Lin CC, Keller JJ, Kang JH, et al. Obstructive sleep apnea is associated with an increased risk of venous thromboembolism. J Vasc Surg Venous Lymphat Disord, 2013, 1(2): 139-145.
|
20. |
Peng YH, Liao WC, Chung WS, et al. Association between obstructive sleep apnea and deep vein thrombosis/pulmonary embolism: a population-based retrospective cohort study. Thromb Res, 2014, 134(2): 340-345.
|
21. |
Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev, 2009, 23(5): 225-229.
|
22. |
García-Ortega A, Mañas E, López-Reyes R, et al. Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications. Eur Respir J, 2019, 53(2): 1800893.
|
23. |
Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation, 2008, 117(1): 93-102.
|
24. |
Yang G, De Staercke C, Hooper WC. The effects of obesity on venous thromboembolism: a review. Open J Prev Med, 2012, 2(4): 499-509.
|
25. |
Wang J, Yu W, Gao M, et al. Impact of obstructive sleep apnea syndrome on endothelial function, arterial stiffening, and serum inflammatory markers: an updated meta-analysis and metaregression of 18 studies. J Am Heart Assoc, 2015, 4(11): e002454.
|
26. |
Thomas SR, Chen K, Keaney JF Jr. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem, 2002, 277(8): 6017-6024.
|
27. |
Tanaka T, Nakamura H, Yodoi J, et al. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med, 2005, 38(9): 1231-1242.
|
28. |
Kokturk O, Ciftci TU, Mollarecep E, et al. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J, 2005, 46(5): 801-809.
|
29. |
von Känel R, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath, 2006, 10(3): 139-146.
|
30. |
Huang Z, Zheng Z, Pang L, et al. The association between obstructive sleep apnea and venous thromboembolism: a bidirectional two-sample mendelian randomization study. Thromb Haemost, 2024, 124(11): 1061-1074.
|